Tag: RNA-based drug development
$96m RNA pilot manufacturing facility to be established in NSW
The NSW Government has announced a $96 million investment in a first-of-its-kind pilot facility in Australia that will develop mRNA and RNA vaccines and...
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
